Search Within

Principal Biostatisticians

  1. "2019"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (7)
Groups
  1. Department of Medicine (15)
  2. Epidemiology and Biostatistics (15)
  3. Survivorship Research (11)
  4. Center for Hematologic Malignancies (9)
  5. Hematologic Malignancies, Division of (9)
  6. Solid Tumor Oncology Division (9)

More Groups

People
  1. Esther Drill (15)
  2. Matthew Matasar (7)
  3. Andrew Zelenetz (6)
  4. Anita Kumar (6)
  5. Anas Younes (5)
  6. Ariela Noy (5)

More People

Years
  1. 2019 (15)
Publications
  1. Blood (4)
  2. Hematological Oncology (2)
  3. Breast Cancer Research and Treatment (1)
  4. Clinical Cancer Research (1)
  5. European Urology Focus (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Society of Hematology (4)
  2. Elsevier Inc. (2)
  3. Wiley Blackwell (2)
  4. American Association for Cancer Research (1)
  5. American Society of Clinical Oncology (1)
  6. Elsevier B.V. (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Retrospective analysis of gemcitabine and oxaliplatin (GemOx)-based treatment in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
    Meeting Abstract

    Schade, J. R.; Kim, C.; Drill, E.; Qiu, A.; Batlevi, C. L.; Caron, P.; Colbourn, D. S.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Expectant management of extranodal marginal zone lymphoma of bronchial-associated lymphoid tissue (BALT)
    Meeting Abstract

    Leyfman, Y.; Joffe, E.; Drill, E.; Rajeeve, S.; Zelenetz, A. D.; Palomba, M. L. L.; Moskowitz, C. H.; Portlock, C. S.; Noy, A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin combined with AVD chemotherapy and radiotherapy in patients with newly diagnosed early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L. E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S.; Drill, E.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A phase II, multicenter study of high dose chemotherapy with autologous stem cell transplant followed by maintenance therapy with romidepsin for T-cell lymphoma
    Meeting Abstract

    Khan, N.; Shustov, A. R.; Khimani, F.; Shadman, M.; Cassaday, R. D.; Ruan, J.; Moskowitz, A. J.; Zelenetz, A. D.; Noy, A.; Straus, D. J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • MILO/ENGOT-ov11: Phase-3 study of binimetinib versus physician's choice chemotherapy (PCC) in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum
    Meeting Abstract

    Grisham, R.; Monk, B. J.; Banerjee, S.; Coleman, R. L.; Oza, A. M.; Oehler, M. K.; Kalbacher, E.; Mirza Raza, M.; del Campo, J. M.; Marth, C.; more...
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Real-world assessment of practice efficiency with the introduction of subcutaneous rituximab
    Meeting Abstract

    Qiu, A.; Shapouri, S.; Drill, E. N.; Schade, J.; Ravelo, A.; Ni, A.; To, T. M.; Dawson, K. L.; Matasar, M. J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Distinct histomorphological features are associated with IDH1 mutation in intrahepatic cholangiocarcinoma
    Journal Article

    Wang, T.; Drill, E.; Vakiani, E.; Pak, L. M.; Boerner, T.; Askan, G.; Schvartzman, J. M.; Simpson, A. L.; Jarnagin, W. R.; Sigel, C. S.
    Human Pathology (2019)

    Fulltext@MSK | Save
  • Real‐world assessment of practice efficiency with the introduction of subcutaneous rituximab
    Meeting Abstract

    Matasar, M. J.; Qiu, A.; Shapouri, S.; Drill, E. N.; Schade, J.; Ravelo, A.; Ni, A.; To, T. M.; Dawson, K. L.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Incidence and treatment outcomes of patients with transformed marginal zone lymphoma treated with RCHOP‐like regimens
    Meeting Abstract

    Rajeeve, S.; Bobillo, S. V.; Zelenetz, A. D.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; Moskowitz, A. J.; Hamlin, P. A.; Matasar, M. J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction
    Journal Article

    Hussain, Y.; Drill, E.; Dang, C. T.; Liu, J. E.; Steingart, R. M.; Yu, A. F.
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save